Acute ethanol challenge inhibits glycogen synthase kinase-3 in the rat prefrontal cortex

International Journal of Neuropsychopharmacology

Volumn 12, Issue 2, 2009, Pages 275-280

  Neznanova, Olga ^a,b   Björk, Karl ^a   Rimondini, Roberto ^c   Hansson, Anita C ^a   Hyytiä, Petri ^d   Heilig, Markus ^a   Sommer, Wolfgang H ^a,e  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^e CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

Author keywords

Alcohol use disorder; Animal model; Reinforcement; Western blotting

Indexed keywords

ALCOHOL; GLYCOGEN SYNTHASE KINASE 3BETA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; CENTRAL DEPRESSANT AGENT; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; ONCOPROTEIN; SERINE; THREONINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN PHOSPHORYLATION; RAT; ANIMAL; DRUG EFFECT; ENZYMOLOGY; METABOLISM; PHOSPHORYLATION;

ANIMALS; CENTRAL NERVOUS SYSTEM DEPRESSANTS; ETHANOL; GLYCOGEN SYNTHASE KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASE 3; NUCLEUS ACCUMBENS; ONCOGENE PROTEIN V-AKT; PHOSPHORYLATION; PREFRONTAL CORTEX; RATS; SERINE; THREONINE;

EID: 67049098282     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145708009620     Document Type: Article

References (28)

1. Arlinde C, Sommer W, Bjork K, Reimers M, Hyytia P, Kiianmaa K, Heilig M (2004). A cluster of differentially expressed signal transduction genes identified by microarray analysis in a rat genetic model of alcoholism. Pharmacogenomics Journal 4, 208-218.
2. Beaulieu JM (2007). Not only lithium: regulation of glycogen synthase kinase-3 by antipsychotics and serotonergic drugs. International Journal of Neuropsychopharmacology 10, 3-6.
3. Björk K, Rimondini R, Hansson AC, Terasmaa A, Hyytia P, Heilig M, Sommer WH (2008). Modulation of voluntary ethanol consumption by beta-arrestin 2. FASEB Journal 22, 2552-2560.
4. Chandler LJ, Sutton G (2005). Acute ethanol inhibits extracellular signal-regulated kinase, protein kinase B, and adenosine 3k:5k-cyclic monophosphate response element binding protein activity in an age- and brain region-speciric manner. Alcoholism: Clinical and Experimental Research 29, 672-682.
5. Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA (1995). Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378, 785-789.
6. Davis MI, Szarowski D, Turner JN, Morrisett RA, Shain W (1999). In vivo activation and in situ BDNF-stimulated nuclear translocation of mitogen-activated/extracellular signal-regulated protein kinase is inhibited by ethanol in the developing rat hippocampus. Neuroscience Letters 272, 95-98.
7. Doble BW, Woodgett JR (2003). GSK-3: tricks of the trade for a multi-tasking kinase. Journal of Cell Science 116, 1175-1186.
8. Egli M (2005). Can experimental paradigms and animal models be used to discover clinically effective medications for alcoholism? Addiction Biology 10, 309-319.
9. Frame S, Cohen P, Biondi RM (2001). A common phosphate binding site explains the unique substrate specificity of GSK3 and its inactivation by phosphorylation. Molecular Cell 7, 1321-1327.
10. Gilman JM, Ramchandani VA, Davis MB, Bjork JM, Hommer DW (2008). Why we like to drink: a functional magnetic resonance imaging study of the rewarding and anxiolytic effects of alcohol. Journal of Neuroscience 28, 4583-4591.
11. Gould TD, Manji HK (2005). Glycogen synthase kinase-3: a putative molecular target for lithium mimetic drugs. Neuropsychopharmacology 30, 1223-1237.
12. Hansson AC, Bermudez-Silva FJ, Malinen H, Hyytia P, Sanchez-Vera I, Rimondini R, Rodriguez de FF, Kunos G, Sommer WH, Heilig M (2007). Genetic impairment of frontocortical endocannabinoid degradation and high alcohol preference. Neuropsychopharmacology 32, 117-126.
13. Hansson AC, Rimondini R, Neznanova O, Sommer WH, Heilig M (2008). Neuroplasticity in brain reward circuitry following a history of ethanol dependence. European Journal of Neuroscience 27, 1912-1922.
14. He L, Marecki JC, Serrero G, Simmen FA, Ronis MJ, Badger TM (2007). Dose-dependent effects of alcohol on insulin signaling: partial explanation for biphasic alcohol impact on human health. Molecular Endocrinology 21, 2541-2550.
15. Jope RS, Johnson GV (2004). The glamour and gloom of glycogen synthase kinase-3. Trends in Biochemical Sciences 29, 95-102.
16. Kalluri HS, Ticku MK (2002). Ethanol-mediated inhibition of mitogen-activated protein kinase phosphorylation in mouse brain. European Journal of Pharmacology 439, 53-58.
17. Klein PS, Melton DA (1996). A molecular mechanism for the effect of lithium on development. Proceedings of the National Academy of USA 93, 8455-8459.
18. Koob GF (2003). Alcoholism: allostasis and beyosnd. Alcoholism: Clinical and Experimental Research 27, 232-243.
19. Lu L, Koya E, Zhai H, Hope BT, Shaham Y (2006). Role of ERK in cocaine addiction. Trends in Neurosciences 29, 695-703.
20. Mokdad AH, Marks JS, Stroup DF, Gerberding JL (2004). Actual causes of death in the United States, 2000. Journal of the American Medical Association 291, 1238-1245.
21. Ozaita A, Puighermanal E, Maldonado R (2007). Regulation of PI3K/Akt/GSK-3 pathway by cannabinoids in the brain. Journal of Neurochemistry 102, 1105-1114.
22. Paxinos G, Watson C (1986). The Rat Brain in Stereotaxic Coordinates, 2nd edn. San Diego: Academic Press.
23. Sanchis-Segura C, Spanagel R (2006). Behavioural assessment of drug reinforcement and addictive features in rodents: an overview. Addiction Biology 11, 2-38.
24. Sanna PP, Simpson C, Lutjens R, Koob G (2002). ERK regulation in chronic ethanol exposure and withdrawal. Brain Research 948, 186-191.
25. Sommer W, Arlinde C, Caberlotto L, Thorsell A, Hyytia P, Heilig M (2001). Differential expression of diacylglycerol kinase iota and L18A mRNAs in the brains of alcohol-preferring AA and alcohol-avoiding ANA rats. Molecular Psychiatry 6, 103-108.
26. Sommer W, Hyytia P, Kiianmaa K (2006). The alcohol-preferring AA and alcohol-avoiding ANA rats: neurobiology of the regulation of alcohol drinking. Addiction Biology 11, 289-309.
27. Sommer WH, Rimondini R, Hansson AC, Hipskind PA, Gehlert DR, Barr CS, Heilig M (2008). Upregulation of voluntary alcohol intake, behavioral sensitivity to stress, and amygdala crhr1 expression following a history of dependence. Biological Psychiatry 63, 139-145.
28. Vengeliene V, Bilbao A, Molander A, Spanagel R (2008). Neuropharmacology of alcohol addiction. British Journal of Pharmacology 154, 299-315.